- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
NF-?B p65 AntibodyMouse Monoclonal Antibody to NF-?B p65
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AO1321a | 0.1ml 400 ul | 7-10 days | $ 325.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
NF-?B p65 Antibody - Product info | |
| Application | WB
|
| Primary Accession | Q04206 |
| Other Accession | NP_068810.3 |
| Reactivity | Human, Mouse |
| Isotype | Mouse IgG1 |
| Clone Names | 6H7 |
| Calculated MW | 60219 Da |
NF-?B p65 Antibody - Additional info | |
| Gene ID 5970 | |
| Other Names NFkappaB p65; p65; NFKB3; RELA | |
| Target/Specificity Purified recombinant fragment of human NF-?B p65 expressed in E. Coli. | |
| Dilution WB~~1:500 - 2000. | |
| Format Purified recombinant fragment of human NF-?B p65 expressed in E. Coli. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions NF-?B p65 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. | |
NF-?B p65 Antibody - Protein Information | |
| Name RELA | |
| Synonyms NFKB3 | |
| Function NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1 | |
| Cellular Location Nucleus. Cytoplasm. Note=Colocalized with DDX1 in the nucleus upon TNF-alpha induction (By similarity) Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B). Colocalizes with GFI1 in the nucleus after LPS stimulation | |
NF-?B p65 Antibody - Related products
AP3176a: Phospho-NFKBp65-S536 Antibody
AP3178a: Phospho-NFKB-S536 Antibody
AP3717a: Phospho-NF kappa B-S276 Antibody
AP3749a: Phospho-NF kappa B-S536 Antibody
AP6826a: RELA Antibody (N-term)
AP6826c: RELA Antibody (Center)
LY10116a: RELA Over-expression Lysate
BP3176a: Phospho-NFKBp65-S536 Antibody Blocking Peptide
BP3178a: Phospho-NFKB-pS536 Antibody Blocking Peptide
BP3717a: Phospho-NF kappa B-S276 Antibody Blocking Peptide
BP6826a: RELA Antibody (N-term) Blocking Peptide
BP6826c: RELA Antibody (Center) Blocking Peptide
BP9125c: NF kappa B-S276 Antibody Blocking Peptide
BP9455a: NF kappa B-S276 Blocking Peptide
AT3616a: RELA Antibody (monoclonal) (M01)
AJ1537a: NF-kappaB Antibody (p65 subunit)
NF-?B p65 Antibody - Application data
-
Figure 1: Western blot analysis using anti-NF-kB p65 mAb against Jurkat (1), K562 (2) and NIH/3T3 (3) cell lysate.
NF-?B p65 Antibody - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Transcription factors of the nuclear factor ? B (NF-?B)/Rel family is a ubiquitously expressed transcription factor that regulates many cytokine and Ig genes. It is involved in immune, inflammatory, viral, and acute phase responses. There are five family members in mammals: RelA (p65), c-Rel, RelB, NF-?B1 (p105/p50) and NF-?B2 (p100/p52). The most studied NF-?B complex consists of the p50 and p65 subunits, both containing a 300 amino acid region with homology to the Rel proto-oncogene product. The p50 subunit binds DNA, whereas the p65 subunit is responsible for the interaction of NF-?B with its inhibitor, I?B. In most cell types, the p50/p65 heterodimer is located within the cytoplasm complexed to I?B. This complex prevents nuclear translocation and activity of NF-?B. In response to stimuli such as cytokines, LPS, and viral infections, I?B is phosphorylated at critical residues. This phosphorylation induces dissociation of the I?B/NF-?B complex, allowing the free heterodimeric NF-?B to form a heterotetramer that translocates to the nucleus. In the nucleus, it binds to the ?B site within promoters and enhancers and functions as a transcriptional activator.
REFERENCES
1. Nature. 1997 Aug 7;388(6642):548-54.
2. Cell. 1998 Dec 11;95(6):749-58.
3. J Biol Chem. 2000 Jun 16;275(24):18180-7.